Antibody Response to Lipopolysaccharide in Patients Colonized or Infected with an Endemic Strain of Acinetobacter Genomic Species 13 Sensu Tjernberg and Ursing

AUTOR(ES)

Pantophlet, Ralph

FONTE

American Society for Microbiology

RESUMO

The levels of antilipopolysaccharide (anti-LPS) antibodies in patients colonized with an endemic Acinetobacter strain were compared to those in patients with bloodstream infections. Seropositivity and seronegativity correlated with positive and negative blood cultures, respectively, indicating that determination of the level of anti-LPS antibodies is useful for diagnosing Acinetobacter infections.

Documentos Relacionados

• Use of a Murine O-Antigen-Specific Monoclonal Antibody To Identify Acinetobacter Strains of Unnamed Genomic Species 13 Sensu Tjernberg and Ursing
• Endemic and Epidemic Acinetobacter Species in a University Hospital: an 8-Year Survey▿
• Genomic Characterization of an Endemic Mycobacterium tuberculosis Strain: Evolutionary and Epidemiologic Implications
• Comparison of spleen cell proliferation in response to Brucella abortus 2308 lipopolysaccharide or proteins in mice vaccinated with strain 19 or RB51.
• Human Antibody Response to Helicobacter pylori Lipopolysaccharide: Presence of an Immunodominant Epitope in the Polysaccharide Chain of Lipopolysaccharide